Skip to main content
. 2018 Oct 26;19(11):3352. doi: 10.3390/ijms19113352
BV Bevacizumab
BCA Bicinchoninic Acid
CL Chemiluminescence
DCC N,N′-dicyclohexylcarbodimide
DHE Dihydroethidium
ECL Enhanced chemiluminescence
EGFR Epidermal growth factor receptor
ESR1 Estrogen receptor α
FDA Food and drug administration
HER2 Human epidermal receptor 2
mAb(s) Monoclonal antibody(ies)
MTT Tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
PAGE Polyacrylamide gel electrophoresis
PR Progesterone receptor
ROS Reactive oxygen specieis
Se Selenium
Se-BV Selenobevacizumab
Se-TZ Selenotrastuzumab
THF Tetrahydrofuran
TNBC Triple negative breast cancer
TZ Trastuzumab
VEGF Vascular endothelial growth factor
VEGFR Vascular endothelial growth factor receptor